POC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.80770978583678E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.96330004978529E-09 |
Normal-vs-Stage2 |
1.1486000000005E-06 |
Normal-vs-Stage3 |
1.16839999897422E-08 |
Normal-vs-Stage4 |
6.37490060739765E-11 |
Stage1-vs-Stage2 |
1.171360E-01 |
Stage1-vs-Stage3 |
4.683000E-01 |
Stage1-vs-Stage4 |
1.424280E-02 |
Stage2-vs-Stage3 |
2.767400E-01 |
Stage2-vs-Stage4 |
8.781600E-01 |
Stage3-vs-Stage4 |
8.843600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.32993657490033E-12 |
Normal-vs-AfricanAmerican |
2.31719999999047E-05 |
Normal-vs-Asian |
1.215480E-04 |
Caucasian-vs-AfricanAmerican |
8.601400E-01 |
Caucasian-vs-Asian |
2.278600E-01 |
AfricanAmerican-vs-Asian |
2.565800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.78608255857671E-12 |
Normal-vs-Female |
2.78860001756698E-09 |
Male-vs-Female |
3.233800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.376100E-04 |
Normal-vs-Age(41-60Yrs) |
3.13429948661792E-10 |
Normal-vs-Age(61-80Yrs) |
9.04587516004085E-12 |
Normal-vs-Age(81-100Yrs) |
6.161900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.482000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.690400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.886200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.930400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.880200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.249400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.541000E-03 |
Normal-vs-Grade 2 |
3.78090003749776E-10 |
Normal-vs-Grade 3 |
7.11060099689576E-11 |
Normal-vs-Grade 4 |
4.39239999927565E-09 |
Grade 1-vs-Grade 2 |
2.592400E-01 |
Grade 1-vs-Grade 3 |
1.923960E-01 |
Grade 1-vs-Grade 4 |
5.917800E-02 |
Grade 2-vs-Grade 3 |
7.840200E-01 |
Grade 2-vs-Grade 4 |
2.127800E-01 |
Grade 3-vs-Grade 4 |
2.655800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.78460004738457E-09 |
Normal-vs-ccB subtype |
3.76070286023378E-11 |
ccA subtype-vs-ccB subtype |
1.714760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.99299465819536E-11 |
Normal-vs-N1 |
4.10170000186838E-08 |
N0-vs-N1 |
8.689900E-02 |
|
|